| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |